--2025/Q2-- / 419.800M--
--2024/Q4-- / 390.800M--
--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 17.500
- +1.007+6.10%
Trading Dec 2 09:36 ET
6.15BMarket Cap192.31P/E (TTM)
17.850High17.500Low4.42KVolume17.700Open16.493Pre Close78.29KTurnover0.03%Turnover Ratio1750.00P/E (Static)351.68MShares19.99052wk High23.40P/B297.50MFloat Cap14.44052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM2.12%Amplitude14.440Historical Low17.732Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Telix Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
